226 related articles for article (PubMed ID: 35022331)
1. TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer.
Zhang G; Luo X; Wang Z; Xu J; Zhang W; Chen E; Meng Q; Wang D; Huang X; Zhou W; Song Z
Aging (Albany NY); 2022 Jan; 14(1):297-315. PubMed ID: 35022331
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.
Chen RM; Chiou YS; Chong QY; Poh HM; Tan TZ; Zhang MY; Ma L; Zhu T; Pandey V; Basappa ; Kumar AP; Lobie PE
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835445
[TBL] [Abstract][Full Text] [Related]
4. TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer.
Li Y; Xu C; Zhu R; Shen L; Hu G; Tao K; Tao F; Lu Z; Zhang G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7235-7246. PubMed ID: 36905423
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
Xu T; Zhou M; Peng L; Kong S; Miao R; Shi Y; Sheng H; Li L
Int J Clin Exp Pathol; 2014; 7(11):7432-41. PubMed ID: 25550778
[TBL] [Abstract][Full Text] [Related]
6. PTPN6 promotes chemosensitivity of colorectal cancer cells via inhibiting the SP1/MAPK signalling pathway.
Fang H; Ma W; Guo X; Wang J
Cell Biochem Funct; 2021 Apr; 39(3):392-400. PubMed ID: 33615510
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.
Xie X; Liu H; Wang Y; Zhou Y; Yu H; Li G; Ruan Z; Li F; Wang X; Zhang J
Oncotarget; 2016 Jul; 7(29):45837-45848. PubMed ID: 27323852
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effects of the aqueous extract of Orostachys japonica A. Berger on 5-fluorouracil-resistant colorectal cancer via MAPK signalling pathways in vitro and in vivo.
Kim JW; Kim SH; Mariappan R; Moon D; Kim J; Yoon SP
J Ethnopharmacol; 2021 Nov; 280():114412. PubMed ID: 34265383
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells.
He L; Zhu H; Zhou S; Wu T; Wu H; Yang H; Mao H; SekharKathera C; Janardhan A; Edick AM; Zhang A; Hu Z; Pan F; Guo Z
Exp Mol Med; 2018 Aug; 50(8):1-12. PubMed ID: 30111797
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.
Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J
J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076
[TBL] [Abstract][Full Text] [Related]
13. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.
Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X
Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619
[TBL] [Abstract][Full Text] [Related]
17. Qizhen capsule inhibits colorectal cancer by inducing NAG-1/GDF15 expression that mediated via MAPK/ERK activation.
Guo D; Guo C; Fang L; Sang T; Wang Y; Wu K; Guo C; Wang Y; Pan H; Chen R; Wang X
J Ethnopharmacol; 2021 Jun; 273():113964. PubMed ID: 33640439
[TBL] [Abstract][Full Text] [Related]
18. The anti-metastatic effect of baicalein on colorectal cancer.
Chai Y; Xu J; Yan B
Oncol Rep; 2017 Apr; 37(4):2317-2323. PubMed ID: 28259937
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer.
Wu DW; Huang CC; Chang SW; Chen TH; Lee H
Cell Death Differ; 2015 May; 22(5):779-89. PubMed ID: 25323586
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A
J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
